Hakutulokset - Mary Flanagan Quinn
- Näytetään 1 - 2 yhteensä 2 tuloksesta
-
1
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors Tekijä Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz
Julkaistu 2014Artigo -
2
Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors Tekijä Patricia LoRusso, Martin J. Edelman, S. Bever, Karen Forman, MaryJo Pilat, Mary Flanagan Quinn, Jing Li, Elisabeth I. Heath, Lisa Malburg, Patrick Klein, Christopher P. Leamon, Richard A. Messmann, Edward A. Sausville
Julkaistu 2012Artigo
Työkalut:
Liittyvät aiheet
Cancer
Chemotherapy
Internal medicine
Medicine
Pharmacology
Adverse effect
Anesthesia
Astrobiology
Bolus (digestion)
CHEK1
Cell cycle
Cell cycle checkpoint
Cyclophosphamide
Gastroenterology
Gemcitabine
Nausea
Ovarian cancer
Pharmacokinetics
Physics
Refractory (planetary science)
Toxicity
Vinca alkaloid
Vincristine
Vomiting